Free Trial

Enlivex Therapeutics (ENLV) Earnings Date, Estimates & Call Transcripts

Enlivex Therapeutics logo
$0.77 -0.03 (-4.12%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$0.80 +0.03 (+3.90%)
As of 05/8/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Enlivex Therapeutics Earnings Summary

Enlivex Therapeutics posted Q3 2025 earnings on November 14, 2025, reporting an EPS of -$0.09, which topped analysts' consensus estimates of -$0.12 by $0.03. With a trailing EPS of -$0.55, Enlivex Therapeutics' earnings are expected to decrease next year, from ($0.08) to ($0.09) per share.

Latest Q3
Earnings Date
Nov. 14Estimated
Consensus EPS
(Nov. 14)
-$0.12
Actual EPS
(Nov. 14)
-$0.09 Beat By $0.03
Get Enlivex Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enlivex Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ENLV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Enlivex Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.02-$0.02-$0.02
Q2 20261-$0.02-$0.02-$0.02
Q3 20261-$0.02-$0.02-$0.02
Q4 20261-$0.02-$0.02-$0.02
FY 2026 4 -$0.08 -$0.08 -$0.08
Q1 20271-$0.02-$0.02-$0.02
Q2 20271-$0.02-$0.02-$0.02
Q3 20271-$0.02-$0.02-$0.02
Q4 20271-$0.02-$0.02-$0.02

Enlivex Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/14/2025Q3 2025-$0.12-$0.0924+$0.0276-$0.0924--
5/30/2025Q1 2025-$0.16-$0.15+$0.01-$0.15--
3/31/2025Q4 2024-$0.16-$0.23 -$0.07-$0.23--
11/29/2024Q3 2024-$0.16-$0.12+$0.04-$0.12--
8/30/2024Q2 2024-$0.22-$0.16+$0.06-$0.16--
6/14/2024Q1 2024-$0.25-$0.22+$0.03-$0.22--

Data powered by Fiscal.ai.

Enlivex Therapeutics Earnings - Frequently Asked Questions

Enlivex Therapeutics (NASDAQ:ENLV) last announced its quarterly earning data on Friday, November 14, 2025. Learn more on ENLV's earnings history.

In the previous quarter, Enlivex Therapeutics (NASDAQ:ENLV) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.03. Learn more on analysts' earnings estimate vs. ENLV's actual earnings.

Enlivex Therapeutics (NASDAQ:ENLV) has a recorded net income of $1.24 billion. ENLV has generated -$0.55 earnings per share over the last four quarters.

Enlivex Therapeutics' earnings are expected to decrease from ($0.08) per share to ($0.09) per share in the next year.


This page (NASDAQ:ENLV) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners